Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-idiotypic antibodies neutralizing the inhibitory activity of an inhibitory antibody directed against the C1 domain of Factor VIII

Anti-idiotypic antibodies neutralizing the inhibitory activity of an inhibitory antibody directed against the C1 domain of Factor VIII

US Patent 8110190 · Granted Feb 7, 2012

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunogenic peptides comprising an MHC class II T cell epitope and a redox motif2024
Methods and compounds for eliminating immune responses to therapeutic agents2023
Peptides and methods for the treatment of diabetes2023
Immunogenic peptides and their use in immune disorders2023
Peptides and methods for the treatment of diabetes2022
Modulation of antigen immunogenicity by addition of epitopes recognized by NKT c2022
Method for the detection, preparation and depletion of CD4+ t lymphocytes2022
Immunogenic peptides for use in the prevention and/or treatment of infectious di2021
Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cell2021
Immunotherapy targeting intracellular pathogens2021
Modified epitopes for boosting CD4+ T-cell responses2021
Peptides and methods for the treatment of diabetes2020